Haemonetics Corp. buy Robert W. Baird
Start price
26.06.25
/
50%
€62.50
Target price
26.06.26
€74.44
Performance (%)
-12.80%
Price
03.03.26
€56.50
Summary
This prediction is currently active. The price of Haemonetics Corp. has decreased since the start of the prediction. Compared to the start price this results in a performance of -12.80%. This prediction currently runs until 26.06.26. The prediction end date can be changed by Robert_W__Baird at any time. Robert_W__Baird has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Haemonetics Corp. | - | - |
| iShares Core DAX® | -0.975% | -4.716% |
| iShares Nasdaq 100 | 1.163% | 1.881% |
| iShares Nikkei 225® | -1.593% | -5.385% |
| iShares S&P 500 | -0.278% | 0.327% |
Comments by Robert_W__Baird for this prediction
In the thread Haemonetics Corp. diskutieren
Haemonetics Corporation (NYSE: HAE) is now covered by analysts at Robert W. Baird. They set an "outperform" rating and a $87.00 price target on the stock.
Ratings data for HAE provided by MarketBeat
Stopped prediction by Robert_W__Baird for Haemonetics Corp.
Haemonetics Corp.
Start price
Target price
Perf. (%)
€67.50
15.12.25
15.12.25
€84.33
15.12.26
15.12.26
-16.30%
03.03.26
03.03.26
